Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 883.50
+22.00 (2.55%)
Jan 23, 2026, 3:29 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 108.44 billion as of January 23, 2026. Its market cap has decreased by -11.80% in one year.
Market Cap
108.44B
Enterprise Value
102.51B
Revenue
25.12B
Ranking
n/a
PE Ratio
19.97
Stock Price
883.50
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 108.44B, an increase of 18.24%. That is a compound annual growth rate of 3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 108.44B | -3.57% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 283.92B |
| Wockhardt | 219.14B |
| Piramal Pharma | 205.96B |
| Eris Lifesciences | 191.80B |
| Alembic Pharmaceuticals | 151.24B |
| NATCO Pharma | 150.41B |
| Cohance Lifesciences | 148.00B |
| Strides Pharma Science | 79.69B |